Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Gecko

Product Description

Gecko 150 pixels JPEG1.jpgThe Gecko Microplate & Petri  Barcode Labeller is designed to deal with the day to day needs of either a high throughput or medium to low throughput lab. With a small footprint allowing limited bench space to be used, the Gecko is a versatile and robust instrument. With a Z-axis movement meaning that no adaptors are required and all label sizes able to be used the Gecko is a versatile, robust and reliable instrument. The Gecko uses either a 300dpi or 600dpi Zebra or Cab printer which is supplied as standard with the system and prints up to six fields (bar codes and human readable) per label. The label can be applied to one or all sides of the microplate and can withstand temperatures of -800C to 1000C. KBiosystems Gecko applies the label then verifies it using a mounted barcode reader before releasing the plate to give the end user full confidence. The data sources are numerous and can be comma-or tab delimited files and spread sheets, 3rd party application driven, pre-printed (sample feed and supply) and with an ODBC compliant LIMS.

The Gecko is easily integrated with stacking robots/stackers from KBiosystems as well as other systems and also be integrated within any OEM plate supply provider. The Gecko is the ideal printing and labelling solution in the market today with the added reassurance of dealing directly with the manufacturer.

Product Gecko
Company KBiosystems
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

KBiosystems
Units 5 to 10 Paycocke Close Basildon Essex

Tel: +44 (0) 1268 522431
Fax: +44 (0) 1268 270231
Email: sales@kbiosystems.com



Scientific News
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?
An MD Anderson study has shown the potential of a simple molecule involved in cancer metabolism as a powerful therapeutic.
Study Reveals Improved Way to Interpret High-Throughput Biological Data
A recent study has revealed a novel workflow, identifying associations between molecules to provide insights into cellular metabolism and gene expression in complex biological systems.
Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.
Researchers Link Liver Disease and Drug Metabolism
Researchers have discovered that nonalcoholic steatohepatitis, an increasingly common but often undiagnosed liver disease, could have significant medical implications for people with type 2 diabetes.
Scientists Create Synthetic Membranes That Grow Like Living Cells
Chemists and biologists at UC San Diego have succeeded in designing and synthesizing an artificial cell membrane capable of sustaining continual growth, just like a living cell.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Team Led by TSRI Scientists Shows AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
New research shows that an experimental vaccine candidate can stimulate immune activity necessary to prevent HIV infection.
The Perfect Partnership: Research & Industry; Software & Instrumentation. It really starts to come together at ASMS 2015
Collaboration and knowledge-sharing were evident everywhere: on the bus, in the hallways and in the bars. This article aims to capture this theme and share with you some of the fruits of this coming together of science and industry.
Metabolite of Cancer Drug More Effective at Treating Aggressive Tumors
Researchers have discovered for the first time that a metabolite of an FDA-approved drug for metastatic prostate cancer, has more anti-cancer properties than its precursor.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!